ArticleFrontiers in pain research (Lausanne, Switzerland)2026
Carbamazepine improves perioperative outcomes in patients with tentorial meningiomas.
Article in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative pain management is critical for patients undergoing surgery for tentorial meningiomas due to the involvement of trigeminal nerve innervation in this region, which often results in severe pain. This study aimed to evaluate the efficacy and safety of carbamazepine (CBZ) in reducing postoperative pain, analgesic consumption, and hospital stay in these patients. Methods: This retrospective study included consecutive patients with tentorial meningiomas who underwent surgical resection between March 2021 and August 2023 at the Second Affiliated Hospital of Zhejiang University. Patients were divided into two groups, with the control group receiving nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids as needed for pain management, while the CBZ group was additionally treated with CBZ at a dosage of 200 mg twice daily postoperatively. Data collected included baseline demographics, postoperative inflammatory markers, liver function, length of hospital stay, total hospital charges, analgesic consumption, and daily pain score. Results: A total of 42 patients were included in the study, with 22 in the control group and 20 in the CBZ group. Although the CBZ group had shorter hospital stays and lower costs, these differences were not statistically significant. The CBZ group reported significantly lower pain scores on postoperative days 2 and 7 ( Conclusions: CBZ effectively reduces postoperative pain, decreases analgesic use without increasing adverse effects in patients with tentorial meningiomas. These findings support the incorporation of CBZ into multimodal pain management strategies for this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.